Top therapeutic areas (TAs) expected to drive biopharma market growth, 2022-2028

1. Oncology: +$142B
2. CNS (Neurology/Central nervous system): +$56B
3. Endocrine: +$38B
4. Immuno-modulators: +$36B
5. Metabolic diseases: +$40B
6. Cardiovascular: +$17B
7. Blood: +$10B
8. Musculo-skeletal: +$11B
9. Other TAs: +$98B
10. Anti-infectives: -$44B

Notes: Expected market growth of top biopharma therapeutic areas from where they were in 2022 to 2028(estimate) in US billions.
Source: EY, How life sciences can make the right deals in a time of change, January 2024
Source URL: https://www.ey.com/en_gl/life-sciences/mergers-acquisitions-...

Printer-friendly versionSend to friendmore...